Neoadjuvant treatment for locally advanced rectal adenocarcinoma with concomitant radiotherapy and oral capecitabine

Journal of B.U.ON.

Volumn 9, Issue 1, 2004, Pages 33-40

  Šlampa, Pavel ^a   Kocakova I ^a   Sefr R ^a   Horova H ^a   Kocak I ^a   Coupek P ^a   Chrenko, V ^a   Spelda S ^a  

^a MASARYK MEMORIAL CANCER INSTITUTE   (Czech Republic)

Author keywords

Capecitabine; Chemoradiation; Downstaging; Preoperative radiotherapy; Radiosensitization; Rectal cancer

Indexed keywords

CAPECITABINE; FLUOROURACIL; FOLINIC ACID;

ADULT; AGED; ANOREXIA; ARTICLE; BODY WEIGHT DISORDER; CANCER ADJUVANT THERAPY; CANCER RADIOTHERAPY; CANCER STAGING; CANCER SURGERY; CLINICAL ARTICLE; CONTROLLED STUDY; DERMATITIS; DIARRHEA; DOSE RESPONSE; DRUG DOSE REGIMEN; DRUG ERUPTION; DRUG SAFETY; FATIGUE; FEMALE; HAND FOOT SYNDROME; HEART INFARCTION; HUMAN; LEUKOPENIA; LINEAR ACCELERATOR; MALE; NAUSEA; PHOTOTHERAPY; POLLAKISURIA; PREOPERATIVE PERIOD; RADIATION DOSE; RADIOSENSITIVITY; RECTUM CARCINOMA; SURGICAL TECHNIQUE; THROMBOCYTOPENIA; VOMITING;

EID: 2442635334     PISSN: 11070625     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (46)

1. Lee JH, Willet CG. Chemoradiation in the therapy of colon and rectum carcinoma. In: Choy H (ed). Chemoradiation in cancer therapy. New Jersey, Humana Press, 2003, pp 271-290.
2. Bosset JF, Maignon P. Adjuvant chemoradiation for rectal cancer. In: Mornex F, Mazeron JJ, Droz JP (eds). Concomitant chemoradiation: Current status and future. Paris: Elsevier, 1999, pp 149-155.
3. Rotman M, Aziz H, Wasserman TH. Chemotherapy and irradiation. In: Perez, CA, Brady LW (eds). Principles & Practice of Radiation Oncology (3rd edn). Philadelphia: Lippincott-Raven Publ, 1997, pp 705-720.
4. Tepper JE, O'Connell MJ, Petroni GR. Adjuvant postoperative fluorouracil-modulated chemotherapy combined with pelvic radiation therapy for rectal cancer: initial results of intergroup 0114. J Clin Oncol 1997; 5: 2030-2039.
5. Wolmark N, Wieand HS, Hyams DM. Randomized trial of postoperative adjuvant chemotherapy with or without radiotherapy for carcinoma of the rectum: NSABP protocol R-02. J Natl Cancer Inst 2000; 5: 388-396.
6. Gastrointestinal Tumor Study Group. Survival after postoperative combination treatment of rectal carcinoma. N Engl J Med 1991; 315: 710-715.
7. Swedish Rectal Cancer Trial. Improved survival with preoperative radiotherapy in resectable rectal cancer. N Engl J Med 1997; 336: 980-987.
8. Martling A, Holm T, Johansson H. The Stockholm II trial on preoperative radiotherapy in rectal carcinoma: long-term follow-up of a population-based study. Cancer 2001; 92: 896-902.
9. Camma C, Giunta M, Fiorica F. Preoperative radiotherapy for resectable rectal cancer: A meta-analysis. JAMA 2000; 284: 1008-1015.
10. Fisher B. Post-operative adjuvant chemotherapy or radiation therapy for rectal cancer: results from NSABP protcol R-01. J Natl Cancer Inst 1988; 80: 21-29.
11. Mendenhall WM, Bland KI, Copeland EM. Does preoperative radiation therapy enhance the probability of local control and survival in high-risk distal rectal cancer? Ann Surg 1992; 215: 696-706.
12. Ahmad NR, Marks G, Mohiuddin M. High-dose preoperative radiation for cancer of the rectum. Impact of radiation dose on patterns of failure and survival. Int J Radiat Oncol Biol Phys 1993; 27: 773-778.
13. Janjan NA, Crane CN, Feig BW et al. Prospective trial of preoperative concomitant boost radiotherapy with continuous infusion 5-fluorouracil for locally advanced rectal cancer. Int J Radiat Oncol Biol Phys 2000; 47: 713-718.
14. Abdelkarim SA, Bieri S, Brandler M. Preoperative hyperfractionated radiotherapy for locally advanced rectal cancers: a phase I-II trial. Int J Radiat Oncol Biol Phys 2002; 54: 1076-1081.
15. Ishikawa T, Utoh M, Sawada N. Tumor selective delivery of 5-fluorouracil by capecitabine a new oral fluoropyrimidine carbamate, in human cancer xenografts. Biochem Pharmacol 1998; 55: 1091-1097.
16. Budman DR, Meropol NG, Creaven P. Preliminary studies of a novel oral fluoropyrimidine carbamate: Capecitabine. J Clin Oncol 1998; 16: 1795-1802.
17. Miwa M, Ura M, Nishida M. Design of a novel oral fluoropyrimide carbamate, capecitabine, which generates 5-fluorouracil selectively in tumors by enzymes concentrated in human liver and cancer tissue. Eur J Cancer 1998; 34: 1274-1281.
18. Schüller J, Cassidy J, Dumont E. Preferential activation of capecitabine in tumor following oral administration in colorectal cancer patients. Cancer Chemother Pharmacol 2000; 45: 291-297.
19. Valentini V, Coco C, Cellini A et al. Ten years of preoperative chemoradiation for extraperitoneal T3 rectal cancer: Acute toxicity, tumor response, and sphincter preservation in three consecutive studies. Int J Radiat Oncol Biol Phys 2001; 51: 371-383.
20. Rich TA, Skibber JM, Ajani T. Preoperative infusional chemoradiation therapy for stage T3 rectal cancer. Int J Radiat Oncol Biol Phys 1995; 32: 1025-1029.
21. Chari RS, Tyler DS, Anscher MS et al. Preopetative radiation and chemotherapy in the treatment of adenocarcinoma of the rectum. Ann Surg 1995; 221: 778-786.
22. Vietti J, Eggerdine F, Valeriote F. Combined effect of X-radiation and 5-FU on survival of transplanted leukemic cells. J Natl Cancer Inst 1971; 47: 865-870.
23. Byfield JE. Theoretical basis and clinical applications of 5-fluorouracil as a radiosensitizer-an overview. In: Rotman M, Rosenthal CJ (eds). Concomitant continuous infusion chemotherapy and radiation. Berlin: Springer-Verlag, 1991, pp 115-127.
24. Byfield JE, Frankel SS, Sharp TR. Phase 1 and pharmacologic study of 72-hour infused 5-fluorouracil and hyperfractioned cyclical radiation. Int J Radiat Oncol Biol Phys 1985; 11: 791-800.
25. Meta-analysis group in cancer. Efficacy of continuous infusion of 5-fluorouracil compared with bolus administration in advanced colorectal cancer. J Clin Oncol 1998; 16: 301-308.
26. Smalley S, Kimler B, Evans R. 5-fluorouracil modulation of radiosensitivity in cultured human carcinoma cells. Int J Radiat Oncol Biol Phys 1991; 20: 207-211.
27. Fabian CJ, Molina R, Slavik M. Pyridoxine therapy for palmar-plantar erythrodysesthesia associated with continuous 5-fluorouracil infusion. Investig New Drugs 1990; 8: 57-63.
28. Rodel C, Fietkau R, Keilholz L. The acute toxicity of simultaneous radiochemotherapy of rectal carcinoma. Strahlenther Onkol 1997; 173: 415-421.
29. Reese T, Tanner J, Frings S. Capecitabine combined with simultaneous radiotherapy in rectal cancer: A phase I study. Int J Radiat Oncol Biol Phys 2000; 48: 20 (abstr).
30. Ngan S, Zalcberg J, Kell A. A phase I study of capecitabine combined with radiotherapy for locally advanced potentially operable rectal cancer. Proc Am Soc Clin Oncol 2001; 20: 591 (abstr#149a).
31. Yoon WH, Choi JH, Kim JR. Enhaced tumoricidal effect of preoperative chemoradiation using capecitabine for locally advanced rectal cancer. Proc Am Soc Clin Oncol 2001; 20: 2165 (abstr #104b).
32. Vaishampayan UN, Ben-Josef E, Philip PA, Vaitkevicius VK, Du W, Levin KJ, Shields AF. A single-institute experience with concurrent capecitabine and radiation therapy in gastrointestinal malignancies. Int J Radiat Oncol Biol Phys 2002; 53: 675-679.
33. Stein TA, Bailey B, Burns GP. Comparison of 5-fluorouracil anabolite levels after intravenous bolus and continuous infusion. Cancer Chemother Pharmacol 1994; 34: 293-296.
34. Hoff PM, Ansari R, Batist G. Comparison of oral capecitabine versus intravenous fluorouracil plus leucovorin as first-line treatment in 605 patients with metastatic colorectal cancer: results of a randomized phase III study. J Clin Oncol 2001; 19: 2282-2292.
35. Makean M, Planting A, Twelves C. Phase I and pharmacologic study of intermittent twice daily oral therapy with capecitabine in patients with advanced and/or metastatic cancer. J Clin Oncol 1998; 16: 2977-2985.
36. Beck A, Etienne MC, Cheradame S. A role for dihydropyrimidine dehydrogenase and thymidylate synthase in tumor sensitivity to fluorouracil. Eur J Cancer 1994; 30: 1517-1522.
37. Valentini V, Coco C, Piccocchi A. Does downstaging predict improved outcome after preoperative chemoradiation for extraperitoneal locally advanced rectal cancer? A longterm analysis of 165 patients. Int J Radiat Oncol Biol Phys 2002; 53: 664-674.
38. Francois Y, Nemoz CJ, Baulieux J, Vignal J. Influence of the interval between preoperative radiation therapy and surgery on downstaging and on the rate of sphincter-sparing surgery for rectal cancer. The Lyon R90-01 randomized trial. J Clin Oncol 1999; 2396-2402.
39. Allen P, Brown B, Skibber J. Prospective trial of preoperative concomitant boost radiotherapy with continuous infusion 5-fluorouracil for locally advanced rectal cancer. Int J Radiat Oncol Biol Phys 2000; 47: 713-718.
40. Tannapfel A, Nusslein S, Katalinic A. Proliferation and apoptosis before and after preoperative simultaneous radiochemotherapy of rectal carcinomas. Strahlenther Onkol 1998; 174: 295-299.
41. Leong T, Guiney M, Ngan S, Mackay J. Preoperative radiotherapy and chemotherapy for non-resectable rectal cancer. Austral N Zealand J Surg 1997; 67: 603-606.
42. Movsas B, Hanlon AL, Lanciano R. Phase I dose escalating trial of hyperfractionated pre-operative chemoradiation for locally advanced rectal cancer. Int J Radiat Oncol Biol Phys 1998; 42: 43-50.
43. Ngan SY, Burmeister BH, Fisher R. Early toxicity from preoperative radiotherapy with continuous infusion 5-fluorouracil for resectable adenocarcinoma of the rectum: A phase II trial for the Trans-Tasman Radiation Oncology Group. Int J Radiat Oncol Biol Phys 2001; 50: 883-887.
44. Grann A, Feng C, Wong D. Preoperative combined modality therapy for clinically resectable T3 rectal adenocarcinoma. Int J Radiat Oncol Biol Phys 2001; 49: 987-995.
45. Marks GJ, Marks JH. Radical sphincter preservation surgery with coloanal anastomosis following high dose external irradiation for very low lying rectal cancer: recent results. Cancer Res 1998; 146: 161-174.
46. Wagman R, Minsky BD, Cohen AM. Sphincter preservation in rectal cancer with preoperative radiation therapy and coloanal anastomosis: long term follow up. Int J Radiat Oncol Biol Phys 1998; 42: 51-57.